<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04235803</url>
  </required_header>
  <id_info>
    <org_study_id>Eye plastic telemedicine</org_study_id>
    <nct_id>NCT04235803</nct_id>
  </id_info>
  <brief_title>Telemedicine Follow-up for Routine, Low-Risk Oculoplastic Surgery</brief_title>
  <official_title>Telemedicine Follow-up for Routine, Low-Risk Oculoplastic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose utilizing a simple telemedical protocol to allow patients to&#xD;
      substitute the first post-operative visit with a remote survey that includes essential&#xD;
      post-operative history, vision measurement, and photographs, all of which can be provided&#xD;
      using a personal computer, tablet, or smart phone. The investigators have selected for this&#xD;
      purpose a subset of oculoplastic procedures involving the eyelid and lacrimal system that&#xD;
      have well-reported low rates of serious complications, since high-risk procedures will likely&#xD;
      always require close, in-person care. The investigators hypothesize that telemedicine&#xD;
      follow-up for the first post-operative week after low-risk oculoplastic surgery will decrease&#xD;
      the time burden on patients without compromising their satisfaction or increase the risk of&#xD;
      late post-operative complications.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2021</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomization to telemedicine follow-up versus routine in-person follow-up for the 1 week assessment after low-risk oculoplastic surgery.</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>FACE-Q 'Satisfaction with Outcome'</measure>
    <time_frame>Approximately 3 months post-operatively</time_frame>
    <description>A patient-reported outcome measure assessing satisfaction with the surgical outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>FACE-Q 'Early Life Impact'</measure>
    <time_frame>Approximately 1 week post-operatively</time_frame>
    <description>A patient-reported outcome measure assessing early life impact of facial plastic surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FACE-Q 'Satisfaction with Doctor'</measure>
    <time_frame>Approximately 3 months post-operatively</time_frame>
    <description>A patient-reported outcome measure assessing satisfaction with the surgeon.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late post-operative complications</measure>
    <time_frame>Between the first and second post-operative visits (approximately 1 week to 3 months)</time_frame>
    <description>Investigator-reported post-operative complications.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time burden</measure>
    <time_frame>Approximately 1 week post-operatively</time_frame>
    <description>Patient-reported time spent on the first post-operative visit, including waiting, travel, the visit, and all forms.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Eyelid Diseases</condition>
  <condition>Ptosis, Eyelid</condition>
  <condition>Blepharoptosis</condition>
  <condition>Dermatochalasis</condition>
  <condition>Ectropion</condition>
  <condition>Entropion</condition>
  <condition>Eyelid Tumor</condition>
  <condition>Skin Cancer, Eyelid</condition>
  <condition>Floppy Eyelid Syndrome</condition>
  <arm_group>
    <arm_group_label>Telemedicine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in the telemedicine arm will have their post-operative week one visit via a telemedicine portal.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patient in the routine arm will have their post-operative week one visit in clinic.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Telemedicine follow-up</intervention_name>
    <description>A telemedicine follow-up form based in REDCap that collects information from the patient including: history, photographs, vision measurement, and questions.</description>
    <arm_group_label>Telemedicine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Are age 18 years or older&#xD;
&#xD;
          -  Are fluent in English&#xD;
&#xD;
          -  Own or have ready access to a smart phone, tablet, or personal computer with high&#xD;
             speed internet&#xD;
&#xD;
          -  Participate in an informed consent process with the surgeon(s) including documentation&#xD;
             of written informed consent&#xD;
&#xD;
          -  Are undergoing a low-risk* eyelid procedure in a clinic, ambulatory surgery center, or&#xD;
             hospital operating room setting, including but not limited to:&#xD;
&#xD;
               -  upper eyelid blepharoplasty repair&#xD;
&#xD;
               -  ectropion repair&#xD;
&#xD;
               -  entropion repair&#xD;
&#xD;
               -  external levator resection&#xD;
&#xD;
               -  internal levator resection&#xD;
&#xD;
               -  eyelid lesion removal and/or biopsy&#xD;
&#xD;
               -  eyelid reconstruction and defect repair including after Mohs' surgery&#xD;
&#xD;
               -  eyelid tightening procedures for Floppy Eyelid Syndrome&#xD;
&#xD;
               -  tarsorrhaphy&#xD;
&#xD;
               -  dacryocystorhinostomy&#xD;
&#xD;
        (*)These listed procedures have a low reported rate of serious complications including&#xD;
        vision loss, infection, severe bleeding, or death; however, surgical risk is ultimately&#xD;
        determined by the surgeon on a per-patient basis, except in those cases specifically&#xD;
        excluded in the subsequent section.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Are under the age of 18 years&#xD;
&#xD;
          -  Are incarcerated&#xD;
&#xD;
          -  Are pregnant or plan to become pregnant during the period of surgery and 3 month&#xD;
             recovery (however these patients are not eligible for elective eyelid surgery)&#xD;
&#xD;
          -  Are not fluent in English&#xD;
&#xD;
          -  Do not have access to or do not feel comfortable using a smart phone, tablet, or&#xD;
             personal computer&#xD;
&#xD;
          -  Lack personal capacity for consent (i.e. those patients requiring consent for the&#xD;
             surgery by a legal representative are excluded)&#xD;
&#xD;
          -  Experience a serious intra-operative complication (this criterion is assessed after&#xD;
             initial consent)&#xD;
&#xD;
          -  Are undergoing eyelid or other oculoplastic procedures that are deemed greater than&#xD;
             low-risk for serious complications, including but not limited to:&#xD;
&#xD;
               -  orbital surgery&#xD;
&#xD;
               -  lower eyelid blepharoplasty&#xD;
&#xD;
               -  repair of extensive eyelid defects following Mohs' surgery (roughly &gt;33%)&#xD;
&#xD;
               -  procedures requiring skin grafting&#xD;
&#xD;
               -  procedures requiring extensive tissue rearrangement&#xD;
&#xD;
               -  procedures involving an implant (e.g. frontalis sling, gold weight implantation;&#xD;
                  except dacryocystorhinostomy due to the low-risk nature of the lacrimal stent)&#xD;
&#xD;
               -  procedures requiring in-person care at the first post-operative week (e.g. suture&#xD;
                  removal, bolster removal, patch removal)&#xD;
&#xD;
        Notably, patients undergoing greater than low risk procedures listed here are absolutely&#xD;
        excluded from this trial. Surgeon assessment of individual patient surgical risk only&#xD;
        applies to those typically low-risk procedures listed in the previous section on inclusion&#xD;
        criteria; reasons for escalation of risk level include patient characteristics (e.g.&#xD;
        frailty, previous infection or wound dehiscence), re-operation/revision status, or other&#xD;
        factors.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Davin C Ashraf, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Davin C Ashraf, MD</last_name>
    <phone>415-353-2800</phone>
    <email>davin.ashraf@ucsf.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Davin C Ashraf, MD</last_name>
      <phone>415-353-2800</phone>
      <email>davin.ashraf@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Davin C Ashraf, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>M Reza Vagefi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert C Kersten, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bryan J Winn, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Seanna Grob, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Vyas KS, Hambrick HR, Shakir A, Morrison SD, Tran DC, Pearson K, Vasconez HC, Mardini S, Gosman AA, Dobke M, Granick MS. A Systematic Review of the Use of Telemedicine in Plastic and Reconstructive Surgery and Dermatology. Ann Plast Surg. 2017 Jun;78(6):736-768. doi: 10.1097/SAP.0000000000001044. Review.</citation>
    <PMID>28328635</PMID>
  </reference>
  <reference>
    <citation>Hwa K, Wren SM. Telehealth follow-up in lieu of postoperative clinic visit for ambulatory surgery: results of a pilot program. JAMA Surg. 2013 Sep;148(9):823-7. doi: 10.1001/jamasurg.2013.2672.</citation>
    <PMID>23842982</PMID>
  </reference>
  <reference>
    <citation>Kummerow Broman K, Roumie CL, Stewart MK, Castellanos JA, Tarpley JL, Dittus RS, Pierce RA. Implementation of a Telephone Postoperative Clinic in an Integrated Health System. J Am Coll Surg. 2016 Oct;223(4):644-51. doi: 10.1016/j.jamcollsurg.2016.07.010. Epub 2016 Aug 18.</citation>
    <PMID>27545100</PMID>
  </reference>
  <reference>
    <citation>Robaldo A, Rousas N, Pane B, Spinella G, Palombo D. Telemedicine in vascular surgery: clinical experience in a single centre. J Telemed Telecare. 2010;16(7):374-7. doi: 10.1258/jtt.2010.091011. Epub 2010 Aug 2.</citation>
    <PMID>20679407</PMID>
  </reference>
  <reference>
    <citation>Williams AM, Bhatti UF, Alam HB, Nikolian VC. The role of telemedicine in postoperative care. Mhealth. 2018 May 2;4:11. doi: 10.21037/mhealth.2018.04.03. eCollection 2018. Review.</citation>
    <PMID>29963556</PMID>
  </reference>
  <reference>
    <citation>Carter SR, Stewart JM, Khan J, Archer KF, Holds JB, Seiff SR, Dailey RA. Infection after blepharoplasty with and without carbon dioxide laser resurfacing. Ophthalmology. 2003 Jul;110(7):1430-2.</citation>
    <PMID>12867404</PMID>
  </reference>
  <reference>
    <citation>Chang S, Lehrman C, Itani K, Rohrich RJ. A systematic review of comparison of upper eyelid involutional ptosis repair techniques: efficacy and complication rates. Plast Reconstr Surg. 2012 Jan;129(1):149-157. doi: 10.1097/PRS.0b013e318230a1c7. Review. Erratum in: Plast Reconstr Surg. 2015 May;135(5):1507.</citation>
    <PMID>22186506</PMID>
  </reference>
  <reference>
    <citation>Lee EW, Holtebeck AC, Harrison AR. Infection rates in outpatient eyelid surgery. Ophthalmic Plast Reconstr Surg. 2009 Mar-Apr;25(2):109-10. doi: 10.1097/IOP.0b013e3181994124.</citation>
    <PMID>19300151</PMID>
  </reference>
  <reference>
    <citation>Mejia JD, Egro FM, Nahai F. Visual loss after blepharoplasty: incidence, management, and preventive measures. Aesthet Surg J. 2011 Jan;31(1):21-9. doi: 10.1177/1090820X10391212. Erratum in: Aesthet Surg J. 2011 Mar 1;31(3):362. Ergo, Francesco Maria [corrected to Egro, Francesco Maria].</citation>
    <PMID>21239669</PMID>
  </reference>
  <reference>
    <citation>Kam KY, Cole CJ, Bunce C, Watson MP, Kamal D, Olver JM. The lateral tarsal strip in ectropion surgery: is it effective when performed in isolation? Eye (Lond). 2012 Jun;26(6):827-32. doi: 10.1038/eye.2012.34. Epub 2012 Mar 9.</citation>
    <PMID>22402697</PMID>
  </reference>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>January 16, 2020</study_first_submitted>
  <study_first_submitted_qc>January 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2020</study_first_posted>
  <last_update_submitted>November 2, 2020</last_update_submitted>
  <last_update_submitted_qc>November 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Oculoplastic</keyword>
  <keyword>Eye plastic</keyword>
  <keyword>Eyelid surgery</keyword>
  <keyword>Telemedicine</keyword>
  <keyword>Remote follow-up</keyword>
  <keyword>Remote visit</keyword>
  <keyword>Blepharoplasty</keyword>
  <keyword>Ptosis repair</keyword>
  <keyword>External levator resection</keyword>
  <keyword>Internal levator resection</keyword>
  <keyword>Ectropion repair</keyword>
  <keyword>Entropion repair</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Neoplasms</mesh_term>
    <mesh_term>Eyelid Neoplasms</mesh_term>
    <mesh_term>Blepharoptosis</mesh_term>
    <mesh_term>Eyelid Diseases</mesh_term>
    <mesh_term>Entropion</mesh_term>
    <mesh_term>Ectropion</mesh_term>
    <mesh_term>Cutis Laxa</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Only plan to share in the event that journal requests de-identified data to be released.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

